Bristol-Myers Sues Teva To Block Generic Baraclude

By Shannon Henson · September 24, 2010, 12:19 PM EDT

Bristol-Myers Squibb Co. has slapped Teva Pharmaceutical Industries Ltd. with a lawsuit, accusing it of infringing a patent covering the hepatitis B drug Baraclude....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Shannon

September 17, 2024
Texas Fertility Clinic Hid 'Catastrophic' Lab Issue, Couples Say
September 16, 2024
Nebraska Medical Cannabis Initiatives Will Be On Nov. Ballot
September 13, 2024
Doctor Charged In DOJ Fraud Suit Gets 6 Months Probation
September 10, 2024
Whole Foods, Hain Denied Full 5th Circ. Review In Baby Food Case
February 13, 2016
Supreme Court Justice Antonin Scalia Dies At 79
October 18, 2010
4 Things To Consider When Deciding To Self-Report
October 11, 2010
Avandia ERISA Class Actions Consolidated
October 05, 2010
Character Testimony Bid Nixed In Insider Trading Case
September 28, 2010
Hospital Network Gets OT Class Action Tossed
September 20, 2010
Boston Sci Buys Asthma Treatment Maker For $443M